資源描述:
《解剖型肝切除和非解剖型肝切除術(shù)治療肝細(xì)胞癌療效比較.pdf》由會(huì)員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在行業(yè)資料-天天文庫。
1、834陜西醫(yī)學(xué)雜志2014年7月第43卷第7期解剖型肝切除和非解剖型肝切除術(shù)治療肝細(xì)胞癌療效比較陜西省延安市人民醫(yī)院肝膽外科(延安71600O)李琦摘要目的:比較解剖型肝切除術(shù)和非解剖型肝切除治療肝細(xì)胞癌臨床療效。方法:收集在肝細(xì)胞癌患者73例手術(shù)治療資料,其中33例采用解剖型肝切除治療,40例采用非解剖型肝切除術(shù),比較兩組臨床療效。結(jié)果:解剖組術(shù)中出血量顯著少于非解剖組,圍術(shù)期輸人血ALB量顯著少于非解剖組。術(shù)后兩組TBIL、DBIL、ALT、AST均有所升高,但非解剖組升高與解剖組比較更明顯;術(shù)后第5天以上各指標(biāo)均顯
2、著下降,與術(shù)后第1天比較,組內(nèi)比較差異有統(tǒng)計(jì)學(xué)意義,而術(shù)后第5天組間比較,差異仍然有顯著差異。非解剖組并發(fā)癥人次、復(fù)發(fā)轉(zhuǎn)移比例、肝內(nèi)復(fù)發(fā)比例均顯著高于解剖組。結(jié)論:與非解剖性肝切除術(shù)比較,解剖性肝切除能夠減少術(shù)中出血量,對(duì)肝功能的損傷較輕,降低術(shù)后并發(fā)癥發(fā)生率和近期復(fù)發(fā)率。主題詞肝腫瘤/外科學(xué)肝切除術(shù)解剖療效比較研究【中圖分類號(hào)】R735.7【文獻(xiàn)標(biāo)識(shí)碼】Adoi:10.3969/j.issn.1000—7377.2014.07.029Clinicalefficacyofanatomicalhepatectomyvers
3、usnon—anatomicalhepatectomyforhepatOceIluIarcarcinomaDepartmentofHepatobiliarySurgery,Yan’anPeople’SHospital,ShanmProvince(Yan’an716000)LiQiABSTRACTObjective:TodiscussclinicalefficacyofanatomicalhepatectomyVersusnon-anatomicalhepa—tectomyforhepatocellularcarcinom
4、a.Methods:Clinicaldataof73caseswithhepatocellularcarcinomawerecollect—ed.Amongthem,33casesweretreatedbyanatomicalhepatectomyand40casesweretreatedbynon—anatomicalhepatectomy.Clinicalefficacyfotwogroupswerecompared.Results:Meanbleedingvolumofgroupanatomicalhepatect
5、omywaslessthanthatofgroupnon—anatomicalhepatectomy,andAIBinfusionofgroupanatomicalhepa—tectomywaslessthanthatofgroupnon-anatomicalhepatectomy.TBIL,DBIL,ALT,ASToftwogroupsincreasedapparentlyafteroperation,andgroupnon-anatomicalhepatectomyincreasedmore.TBII,DBIL,AL
6、T,ASToftwogroupsdecreasedapparentlyat5daysafteroperationcomparedwith1daysafteroperation,butthoseofgroupnon-anatomicalhepatectomywerehigherthangroupanatomicalbepatectomy.Complicationrate,recurrenceandmetas—tasisrate,intrahepaticrecurrencerateofgroupanatomicalhepat
7、ectomywerelowerthangroupnon-anatomicalhepa—tectomy.Conclusion:Comparetonon—anatomicalhepatectomy,anatomicalhepatectomyforhepatocellularcarcino—macanreducebleedingvolum,liverdamage,complicationsandrecurrenceandmetastasis.KEYWORDSLiverneoplasma/SurgeryHepatectomyDi
8、ssectionComparativeeffectiveresearch目前根治性切除術(shù)仍然是治療早期肝細(xì)胞癌的主40例。納入標(biāo)準(zhǔn):①肝細(xì)胞癌診斷明確,首次治療,術(shù)要方法,常見的根治性切除術(shù)有解剖性和非解剖性肝后病理學(xué)結(jié)果為確診標(biāo)準(zhǔn);②術(shù)前評(píng)估為可以手術(shù)治切除術(shù)。有研究顯示解剖性肝切除術(shù)患者術(shù)后復(fù)發(fā)率療,Child—